389 related articles for article (PubMed ID: 7838646)
1. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
Nelson KB; Grether JK
Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
[TBL] [Abstract][Full Text] [Related]
2. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.
Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB
Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199
[TBL] [Abstract][Full Text] [Related]
3. Twinning and cerebral palsy: experience in four northern California counties, births 1983 through 1985.
Grether JK; Nelson KB; Cummins SK
Pediatrics; 1993 Dec; 92(6):854-8. PubMed ID: 8233749
[TBL] [Abstract][Full Text] [Related]
4. Intrapartum magnesium for prevention of cerebral palsy: continuing controversy?
Cahill AG; Stout MJ; Caughey AB
Curr Opin Obstet Gynecol; 2010 Apr; 22(2):122-7. PubMed ID: 20179596
[TBL] [Abstract][Full Text] [Related]
5. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years.
Schendel DE; Berg CJ; Yeargin-Allsopp M; Boyle CA; Decoufle P
JAMA; 1996 Dec; 276(22):1805-10. PubMed ID: 8946900
[TBL] [Abstract][Full Text] [Related]
6. Perinatal factors associated with cerebral palsy in children born in Sweden.
Thorngren-Jerneck K; Herbst A
Obstet Gynecol; 2006 Dec; 108(6):1499-505. PubMed ID: 17138786
[TBL] [Abstract][Full Text] [Related]
7. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
8. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants.
Grether JK; Nelson KB; Emery ES; Cummins SK
J Pediatr; 1996 Mar; 128(3):407-14. PubMed ID: 8774515
[TBL] [Abstract][Full Text] [Related]
9. Antenatal and delivery risk factors and prevalence of cerebral palsy in Duzce (Turkey).
Oztürk A; Demirci F; Yavuz T; Yildiz S; Değirmenci Y; Döşoğlu M; Avşar Y
Brain Dev; 2007 Jan; 29(1):39-42. PubMed ID: 16824718
[TBL] [Abstract][Full Text] [Related]
10. Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage.
Sarkar S; Bhagat I; Dechert R; Schumacher RE; Donn SM
Am J Perinatol; 2009 Jun; 26(6):419-24. PubMed ID: 19267317
[TBL] [Abstract][Full Text] [Related]
11. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
12. Rates of neonatal death and cerebral palsy associated with fetal growth restriction among very low birthweight infants. A temporal analysis.
Spinillo A; Gardella B; Preti E; Zanchi S; Stronati M; Fazzi E
BJOG; 2006 Jul; 113(7):775-80. PubMed ID: 16753043
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and risk factors for cerebral palsy in a total population cohort of low-birthweight (less than 2000g) infants.
Stanley FJ; English DR
Dev Med Child Neurol; 1986 Oct; 28(5):559-68. PubMed ID: 3781100
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term outcomes in babies born after antenatal magnesium treatment.
Mitani M; Matsuda Y; Shimada E;
J Obstet Gynaecol Res; 2011 Nov; 37(11):1609-14. PubMed ID: 21733038
[TBL] [Abstract][Full Text] [Related]
15. Cerebral palsy in very low birthweight infants surviving to 2 years with modern perinatal intensive care.
Kitchen WH; Doyle LW; Ford GW; Rickards AL; Lissenden JV; Ryan MM
Am J Perinatol; 1987 Jan; 4(1):29-35. PubMed ID: 3539133
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the complex relationship between pre-eclampsia, preterm birth and cerebral palsy.
Mann JR; McDermott S; Griffith MI; Hardin J; Gregg A
Paediatr Perinat Epidemiol; 2011 Mar; 25(2):100-10. PubMed ID: 21281322
[TBL] [Abstract][Full Text] [Related]
17. Improved outcomes for very low birth weight infants associated with the use of combined maternal corticosteroids and tocolytics.
Piper JM; Atkinson MW; Mitchel EF; Cliver SP; Snowden M; Wilson SC
J Reprod Med; 1996 Sep; 41(9):692-8. PubMed ID: 8887196
[TBL] [Abstract][Full Text] [Related]
18. Delivery mode and severe intraventricular hemorrhage in single, very low birth weight, vertex infants.
Riskin A; Riskin-Mashiah S; Bader D; Kugelman A; Lerner-Geva L; Boyko V; Reichman B
Obstet Gynecol; 2008 Jul; 112(1):21-8. PubMed ID: 18591303
[TBL] [Abstract][Full Text] [Related]
19. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.
Havranek T; Ashmeade TL; Afanador M; Carver JD
Neonatology; 2011; 100(1):44-9. PubMed ID: 21212694
[TBL] [Abstract][Full Text] [Related]
20. Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate.
Blair E; Palmer L; Stanley F
Pediatrics; 1996 May; 97(5):780-2. PubMed ID: 8628635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
